首页|中药调控铁死亡治疗动脉粥样硬化研究进展

中药调控铁死亡治疗动脉粥样硬化研究进展

扫码查看
动脉粥样硬化是脂质沉积于血管内壁引起的慢性血管性疾病。铁死亡是以铁依赖性和脂质活性氧堆积为主要特征的非凋亡形式的细胞死亡方式。近年研究表明,铁死亡与动脉粥样硬化发生发展密切相关,本文从泡沫细胞形成、血管内皮细胞死亡、血管平滑肌增殖和钙化等方面阐释二者相关性,认为铁死亡贯穿动脉粥样硬化整个病理过程。通过梳理中药调控铁死亡治疗动脉粥样硬化相关机制研究现况可知,中药单体及复方可通过调控铁死亡p53、Nrf2信号通路、氨基酸代谢、脂质代谢等,减轻内皮细胞功能障碍及炎症反应、减缓氧化应激水平、减少动脉血管内膜下氧化脂质堆积,使血管达到稳态,可为探究动脉粥样硬化的临床治疗策略提供参考。
Research Progress in Chinese Materia Medica Regulating Ferroptosis for the Treatment of Atherosclerosis
Atherosclerosis is a chronic vascular disease caused by lipid deposition in the inner wall of blood vessels.Ferroptosis is a non-apoptotic form of cell death characterized by iron dependence and lipid reactive oxygen accumulation.Recent studies have shown that ferroptosis is closely related to the occurrence and development of atherosclerosis.This article explained the correlation between ferroptosis and atherosclerosis from the aspects of foam cell formation,endothelial cell death,vascular smooth muscle proliferation and calcification,and believed that ferroptosis runs through its pathological process.By combing the current research status of the mechanism of Chinese materia medica regulating ferroptosis to treat atherosclerosis,it can be seen that TCM monomers and compounds can reduce endothelial cell dysfunction and inflammatory response,slow down oxidative stress levels,and reduce the accumulation of oxidized lipids under the intima of arterial blood vessels by regulating ferroptosis p53,Nrf2 signaling pathway,amino acid metabolism,lipid metabolism,etc.,so that the blood vessels reach homeostasis,which can provide a reference for the exploration of clinical treatment strategies for atherosclerosis.

Chinese materia medicaferroptosisatherosclerosisreview

王慧影、王绍娜、张良、付海鑫、兰瑞、武继涛

展开 >

河南中医药大学第一临床医学院,河南郑州 450046

河南中医药大学第一附属医院,河南郑州 450000

中药 铁死亡 动脉粥样硬化 综述

2025

中国中医药信息杂志
中国中医科学院中医药信息研究所

中国中医药信息杂志

影响因子:0.889
ISSN:1005-5304
年,卷(期):2025.32(1)